News Details

(As on Nov 29, 2024, 18:24)

Back

Sudarshan Pharma Ind - Announcement under Regulation 30 (LODR)-Acquisition

This is to inform you that the Board of Directors of the Company have, on 28th November, 2024 inter-alia, approved to acquire 10,000 ordinary shares of Singapore Dollar 1/- each of Sudarshan Pharma Industries Private Limited, a company incorporated in Singapore (Unique Entity Number: 202327475M) (100% of the paid-up share capital of Sudarshan Pharma Industries Private Limited). Upon completion of the acquisition, Sudarshan Pharma Industries Private Limited, Singapore would become a wholly owned subsidiary of the Company

ATTENTION INVESTORS

"Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with us. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day.......... Issued in the interest of investors". "Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with us. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day.......... Issued in the interest of investors". "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary".

(Note : Best viewed in 1024 X 768 and above resolution also in IE 9 and above all higher versions.)

Designed, developed and content provided by

News

News Details

SMS Registration

Mobile Trading

Investors Grievances

Invest By QFI

CLIENT LOGIN

FRANCHISEE LOGIN

INTERNET TRADING